Cargando…

Isolated functional tricuspid regurgitation: how to define patients at risk for event?

AIMS: Functional tricuspid regurgitation (TR) is a turning point in cardiac diseases. Symptoms typically appear late. The optimal timing for proposing a valve repair remains a challenge. We sought to analyse the characteristics of right heart remodelling in patients with significant functional TR to...

Descripción completa

Detalles Bibliográficos
Autores principales: L'Official, Guillaume, Vely, Mathilde, Kosmala, Wojciech, Galli, Elena, Guerin, Anne, Chen, Elisabeth, Sportouch, Catherine, Dreyfus, Julien, Oger, Emmanuel, Donal, Erwan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10192508/
https://www.ncbi.nlm.nih.gov/pubmed/36811285
http://dx.doi.org/10.1002/ehf2.14189
_version_ 1785043637246099456
author L'Official, Guillaume
Vely, Mathilde
Kosmala, Wojciech
Galli, Elena
Guerin, Anne
Chen, Elisabeth
Sportouch, Catherine
Dreyfus, Julien
Oger, Emmanuel
Donal, Erwan
author_facet L'Official, Guillaume
Vely, Mathilde
Kosmala, Wojciech
Galli, Elena
Guerin, Anne
Chen, Elisabeth
Sportouch, Catherine
Dreyfus, Julien
Oger, Emmanuel
Donal, Erwan
author_sort L'Official, Guillaume
collection PubMed
description AIMS: Functional tricuspid regurgitation (TR) is a turning point in cardiac diseases. Symptoms typically appear late. The optimal timing for proposing a valve repair remains a challenge. We sought to analyse the characteristics of right heart remodelling in patients with significant functional TR to identify the parameters that could be used in a simple prognostic model predicting clinical events. METHODS AND RESULTS: We designed a prospective observational French multicentre study including 160 patients with significant functional TR (effective regurgitant orifice area > 30 mm(2)) and left ventricular ejection fraction > 40%. Clinical, echocardiographic, and electrocardiogram data were collected at baseline and at the 1 and 2 year follow‐up. The primary outcome was all‐cause death or hospitalization for heart failure. At 2 years, 56 patients (35%) achieved the primary outcome. The subset with events showed more advanced right heart remodelling at baseline, but similar TR severity. Right atrial volume index (RAVI) and the tricuspid annular plane systolic excursion to systolic pulmonary arterial pressure (TAPSE/sPAP) ratio, reflecting right ventricular–pulmonary arterial coupling, were 73 mL/m(2) and 0.40 vs. 64.7 mL/m(2) and 0.50 in the event vs. event‐free groups, respectively (both P < 0.05). None among all the clinical and imaging parameters tested had a significant group × time interaction. The multivariable analysis leads to a model including TAPSE/sPAP ratio > 0.4 (odds ratio = 0.41, 95% confidence limit 0.2 to 0.82) and RAVI > 60 mL/m(2) (odds ratio = 2.13, 95% confidence limit 0.96 to 4.75), providing a clinically valid prognostic evaluation. CONCLUSIONS: RAVI and TAPSE/sPAP are relevant for predicting the risk for event at 2 year follow‐up in patients with an isolated functional TR.
format Online
Article
Text
id pubmed-10192508
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-101925082023-05-19 Isolated functional tricuspid regurgitation: how to define patients at risk for event? L'Official, Guillaume Vely, Mathilde Kosmala, Wojciech Galli, Elena Guerin, Anne Chen, Elisabeth Sportouch, Catherine Dreyfus, Julien Oger, Emmanuel Donal, Erwan ESC Heart Fail Original Articles AIMS: Functional tricuspid regurgitation (TR) is a turning point in cardiac diseases. Symptoms typically appear late. The optimal timing for proposing a valve repair remains a challenge. We sought to analyse the characteristics of right heart remodelling in patients with significant functional TR to identify the parameters that could be used in a simple prognostic model predicting clinical events. METHODS AND RESULTS: We designed a prospective observational French multicentre study including 160 patients with significant functional TR (effective regurgitant orifice area > 30 mm(2)) and left ventricular ejection fraction > 40%. Clinical, echocardiographic, and electrocardiogram data were collected at baseline and at the 1 and 2 year follow‐up. The primary outcome was all‐cause death or hospitalization for heart failure. At 2 years, 56 patients (35%) achieved the primary outcome. The subset with events showed more advanced right heart remodelling at baseline, but similar TR severity. Right atrial volume index (RAVI) and the tricuspid annular plane systolic excursion to systolic pulmonary arterial pressure (TAPSE/sPAP) ratio, reflecting right ventricular–pulmonary arterial coupling, were 73 mL/m(2) and 0.40 vs. 64.7 mL/m(2) and 0.50 in the event vs. event‐free groups, respectively (both P < 0.05). None among all the clinical and imaging parameters tested had a significant group × time interaction. The multivariable analysis leads to a model including TAPSE/sPAP ratio > 0.4 (odds ratio = 0.41, 95% confidence limit 0.2 to 0.82) and RAVI > 60 mL/m(2) (odds ratio = 2.13, 95% confidence limit 0.96 to 4.75), providing a clinically valid prognostic evaluation. CONCLUSIONS: RAVI and TAPSE/sPAP are relevant for predicting the risk for event at 2 year follow‐up in patients with an isolated functional TR. John Wiley and Sons Inc. 2023-02-21 /pmc/articles/PMC10192508/ /pubmed/36811285 http://dx.doi.org/10.1002/ehf2.14189 Text en © 2022 The Authors. ESC Heart Failure published by John Wiley & Sons Ltd on behalf of European Society of Cardiology. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Original Articles
L'Official, Guillaume
Vely, Mathilde
Kosmala, Wojciech
Galli, Elena
Guerin, Anne
Chen, Elisabeth
Sportouch, Catherine
Dreyfus, Julien
Oger, Emmanuel
Donal, Erwan
Isolated functional tricuspid regurgitation: how to define patients at risk for event?
title Isolated functional tricuspid regurgitation: how to define patients at risk for event?
title_full Isolated functional tricuspid regurgitation: how to define patients at risk for event?
title_fullStr Isolated functional tricuspid regurgitation: how to define patients at risk for event?
title_full_unstemmed Isolated functional tricuspid regurgitation: how to define patients at risk for event?
title_short Isolated functional tricuspid regurgitation: how to define patients at risk for event?
title_sort isolated functional tricuspid regurgitation: how to define patients at risk for event?
topic Original Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10192508/
https://www.ncbi.nlm.nih.gov/pubmed/36811285
http://dx.doi.org/10.1002/ehf2.14189
work_keys_str_mv AT lofficialguillaume isolatedfunctionaltricuspidregurgitationhowtodefinepatientsatriskforevent
AT velymathilde isolatedfunctionaltricuspidregurgitationhowtodefinepatientsatriskforevent
AT kosmalawojciech isolatedfunctionaltricuspidregurgitationhowtodefinepatientsatriskforevent
AT gallielena isolatedfunctionaltricuspidregurgitationhowtodefinepatientsatriskforevent
AT guerinanne isolatedfunctionaltricuspidregurgitationhowtodefinepatientsatriskforevent
AT chenelisabeth isolatedfunctionaltricuspidregurgitationhowtodefinepatientsatriskforevent
AT sportouchcatherine isolatedfunctionaltricuspidregurgitationhowtodefinepatientsatriskforevent
AT dreyfusjulien isolatedfunctionaltricuspidregurgitationhowtodefinepatientsatriskforevent
AT ogeremmanuel isolatedfunctionaltricuspidregurgitationhowtodefinepatientsatriskforevent
AT donalerwan isolatedfunctionaltricuspidregurgitationhowtodefinepatientsatriskforevent